Hopen Life Science Ventures
Hopen Life Science Ventures
  • Home
  • Team
  • For the Entrepreneur
  • Portfolio
    • Bjönd Health
    • Cirius Therapeutics
    • Concerto Health
    • Delphinus Medical Tech
    • Intervention Insights
    • Metabolic Solutions
    • NeoChord, Inc.
    • Nymirum
    • Prevacept
    • Sierra Oncology
  • News
  • Contact
  • More
    • Home
    • Team
    • For the Entrepreneur
    • Portfolio
      • Bjönd Health
      • Cirius Therapeutics
      • Concerto Health
      • Delphinus Medical Tech
      • Intervention Insights
      • Metabolic Solutions
      • NeoChord, Inc.
      • Nymirum
      • Prevacept
      • Sierra Oncology
    • News
    • Contact
  • Home
  • Team
  • For the Entrepreneur
  • Portfolio
  • News
  • Contact

Neochord, Inc.

NeoChord, Inc.

NeoChord, Inc. (Eden Prairie, MN) is developing technology invented by cardiac surgeons at the Mayo Clinic who were looking for less invasive ways to repair the mitral valve for the treatment of degenerative mitral regurgitation. The NeoChord DS 1000 device allows sternal sparing, beating heart, apical access to the mitral valve and functions as a delivery system for the placement of artificial chordae tendineae (chords). Ruptured or elongated chords are the primary reason for surgery on the mitral valve today.

Copyright © 2020   Hopen Life Science Ventures - All Rights Reserved